• Room 0G.012 - CEM

    United Kingdom

Accepting PhD Students


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

European Cystic Fibrosis Society: Clinical Trials Network; cystic fibrosis; respiratory disease; bronchiectasis; non-CF brochiectasis

Research Statement

Dr Kathryn Hayes is currently the European Cystic Fibrosis Society Clinical Trials Network (ECFS CTN) Coordinator for the ECFS CTN Standardisation Committee and Research Fellow at the Wellcome Trust-Wolfson Northern Ireland Clinical Research Facility. Prior to this, Dr Hayes held a post-doctoral research post in physiotherapy at Ulster University. She completed her BSc (Hons) Degree in Physiotherapy at Ulster University in 2011, following a BSc and PhD in Economics and Social Sciences at Queen's University in 1994. She joined the ECFS CTN and Queen's University in 2015. 

Dr Haye's research portfolio is focused on respiratory health, with a specific interest in cystic fibrosis (CF). She is coordinator of multiple working groups within the ECFS CTN, exploring patient reported outcome measures (PROMs) with the ECFS CTN and CF Europe PROMs Special Interest Group, working to develop patient-led outcome measures in the field of CF, alongside coordination of working groups on CF diagnostic techniques, inflammatory biomarkers in CF, lung imaging in CF, anthropometrics, microbiological techniques, and respiratory function measurement.

These projects are funded for example by both the ECFS, and the Cystic Fibrosis Foundation Therapeutics Development Network (CFF TDN) and include international, multi-centre trials, employing a wide range of trial designs (RCTs and observational studies) and both quantitative and qualitative methodologies. 

Dr Hayes is currently a member of the International Society for Quality of Life Research and member of the UK & Ireland; Patient Engagement; and Quality of Life in Clinical Practice, Special Interest Groups.

Dr Hayes is currently co-applicant on a Gregory Lemarchal Association funded observational study in France and Belgium to assess patient reported outcome measures in CF, within this trial she co-leads on the validation of a new PROMs tool to assess the impact of cystic fisbrosis transmembrane conductance regulator (CFTR) therapies on quality of life and symptom report in people with CF. 


Dive into the research topics where Kate Hayes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or